Crossmark

Critique on “Elevated levels of advanced glycation end-products AGE10 in patients with reactive arthritis caused by Chlamydia trachomatis and Epstein-Barr virus infection”

Crossref DOI link: https://doi.org/10.1007/s12026-026-09768-0

Published Online: 2026-03-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bibi, Zubaida https://orcid.org/0009-0002-8680-6074
Ali, Kausar https://orcid.org/0009-0003-3360-8442
License Information

Text and Data Mining valid from 2026-03-31

Version of Record valid from 2026-03-31
More Information

Article History

Received: 17 February 2026

Accepted: 15 March 2026

First Online: 31 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below